dc.date.accessioned | 2023-03-06T07:31:43Z | |
dc.date.available | 2023-03-06T07:31:43Z | |
dc.date.issued | 2023 | |
dc.identifier.citation | BMC Cancer. 2023 Feb 27;23(1):192. doi: 10.1186/s12885-023-10662-3. | |
dc.identifier.uri | https://hdl.handle.net/20.500.12619/99912 | |
dc.relation.isversionof | 10.1186/s12885-023-10662-3 | |
dc.relation.isversionof | 10.1186/s12885-023-10662-3 | |
dc.title | Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy | |
dc.relation.journal | BMC Cancer | |
dc.identifier.doi | 10.1186/s12885-023-10662-3 | |
dc.contributor.author | Karacin C | |
dc.contributor.author | Karacin C | |
dc.contributor.author | Oksuzoglu B | |
dc.contributor.author | Demirci A | |
dc.contributor.author | Keskinkılıç M | |
dc.contributor.author | Baytemür NK | |
dc.contributor.author | Yılmaz F | |
dc.contributor.author | Selvi O |
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |